Last reviewed · How we verify
Formula 3 Cough Syrup (SYRUP)
At a glance
| Generic name | SYRUP |
|---|---|
| Sponsor | Vitality Works, Inc. |
| Therapeutic area | Respiratory |
| Phase | FDA-approved |
Approved indications
- cough
- dryness
- minor throat irritation
- bronchial irritation
- common cold
Common side effects
Key clinical trials
- Effects of 2-Aticyto Complex and D-Ribose on Pain and Clinical Course in Patients With Fibromyalgia (NA)
- Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis (PHASE1)
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. (PHASE1)
- Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD (PHASE2)
- A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007) (PHASE1)
- Alginate vs Sucralfate for GERD Symptomatic Relief (PHASE2,PHASE3)
- A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) (PHASE1,PHASE2)
- Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Formula 3 Cough Syrup CI brief — competitive landscape report
- Formula 3 Cough Syrup updates RSS · CI watch RSS
- Vitality Works, Inc. portfolio CI